Trials / Unknown
UnknownNCT02992769
Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
A Nomogram to Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Axillary lymph node status is a vital prognostic factors in breast cancer patients and provides crucial information for making treatment decisions.This projective observational study is planned to identify risk factors for axillary metastases in breast cancer patients with axillary ultrasound and to construct a nomogram to predict the risk of axillary metastases in these patients.
Detailed description
Breast carcinoma is the most common malignancy in women, accounting for 25% of all female cancer cases and 15% of all cancer-related deaths in the world.Lymph node metastasis is a multifactorial event. Among patients with a preoperative axillary ultrasound, almost 40% of patients are pathologically proved to be free from axillary metastasis.The purpose of this study is to develop a nomogram to evaluate the probability of axillary metastasis as a tool to support clinical decision-making.
Conditions
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2016-12-14
- Last updated
- 2016-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02992769. Inclusion in this directory is not an endorsement.